SELCUK HAZIR

Prof. Dr. SELCUK HAZIR

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2016 in European Journal of Plant Pathology
Verified
Journal Article
Closed access
PDF file
SHSELCUK HAZIR
SELCUK HAZIR
David Shapiro IlanDavid Shapiro Ilan
David Shapiro Ilan
CBClive H. Bock
Clive H. Bock
CHCanan Hazir
Canan Hazir
LLLuis G. Leite
Luis G. Leite
MHMichael W. Hotchkiss
Michael W. Hotchkiss

1 September 2015 in Journal of Invertebrate Pathology
Verified
Journal Article
Closed access
AGArife Gumus
Arife Gumus
MKMehmet Karagoz
Mehmet Karagoz
David Shapiro IlanDavid Shapiro Ilan
David Shapiro Ilan
SHSELCUK HAZIR
SELCUK HAZIR

24 June 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SGSebnem Hazal Gulsen
Sebnem Hazal Gulsen
ETEvren Tileklioglu
Evren Tileklioglu
EBEdna Bode
Edna Bode
HCHarun Cimen
Harun Cimen
HEHatice Ertabaklar
Hatice Ertabaklar
SHSELCUK HAZIR
SELCUK HAZIR
Natural products have been proven to be important starting points for the development of new drugs. Bacteria in the genera Photorhabdus and Xenorhabdus produce antimicrobial compounds as secondary metabolites to compete with other organisms. Our study is the first comprehensive study screening the anti-protozoal activity of supernatants containing secondary metabolites produced by 5 Photorhabdus and 22 Xenorhabdus species against human parasitic protozoa, Acanthamoeba castellanii, Entamoeba histolytica, Trichomonas vaginalis, Leishmania tropica and Trypanosoma cruzi, and the identification of novel bioactive antiprotozoal compounds using the easyPACId approach (easy Promoter Activated Compound Identification) method. Though not in all species, both bacterial genera produce antiprotozoal compounds effective on human pathogenic protozoa. The promoter exchange mutants revealed that antiprotozoal bioactive compounds produced by Xenorhabdus bacteria were fabclavines, xenocoumacins, xenorhabdins and PAX peptides. Among the bacteria assessed, only P. namnaoensis appears to have acquired amoebicidal property which is effective on E. histolytica trophozoites. These discovered antiprotozoal compounds might serve as starting points for the development of alternative and novel pharmaceutical agents against human parasitic protozoa in the future.

22 November 2019 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
HOHicran Donmez Ozkan
Hicran Donmez Ozkan
CHCimen Harun
Cimen Harun
DUDerya Ulug
Derya Ulug
SWSebastian Wenski
Sebastian Wenski
SOSenem Yigit Ozer
Senem Yigit Ozer
SHSELCUK HAZIR
SELCUK HAZIR
Xenorhabdus and/or Photorhabdus bacteria produce antibacterial metabolites to protect insect cadavers against food competitors allowing them to survive in nature with their nematode host. The effects of culture supernatant produced by Xenorhabdus and Photorhabdus spp. were investigated against the multidrug-resistant dental root canal pathogen Enterococcus faecalis. The efficacy of seven different cell-free supernatants of Xenorhabdus and Photorhabdus species against E. faecalis was assessed with overlay bioassay and serial dilution techniques. Additionally, time-dependent inactivation of supernatant was evaluated. Among the seven different bacterial species, X. cabanillasii produced the strongest antibacterial effects. Loss of bioactivity in a phosphopantetheinyl transferase-deficient mutant of X. cabanillasii indicated that this activity is likely based on non-ribosomal peptide synthetases (NRPSs) or polyketide synthases (PKSs). Subsequent in silico analysis revealed multiple possible biosynthetic gene clusters (BGCs) in the genome of X. cabanillasii including a BGC homologous to that of zeamine/fabclavine biosynthesis. Fabclavines are NRPS-derived hexapeptides, which are connected by PKS-derived malonate units to an unusual polyamine, also PKS-derived. Due to the known broad-spectrum bioactivity of the fabclavines, we generated a promoter exchange mutant in front of the fabclavine-like BGC. This leads to over-expression by induction or a knock-out by non-induction which resulted in a bioactive and non-bioactive mutant. Furthermore, MS and MS2 experiments confirmed that X. cabanillasii produces the same derivatives as X. budapestensis. The medicament potential of 10-fold concentrated supernatant of induced fcl promoter exchanged X. cabanillasii was also assessed in dental root canals. Calcium hydroxide paste, or chlorhexidine gel, or fabclavine-rich supernatant was applied to root canals. Fabclavine-rich supernatant exhibited the highest inactivation efficacy of ≥3 log10 steps CFU reduction, followed by calcium hydroxide paste (≤2 log10 step). The mean percentage of E. faecalis-free dental root canals after treatment was 63.6, 45.5, and 18.2% for fabclavine, calcium hydroxide, and chlorhexidine, respectively. Fabclavine in liquid form or preferably as a paste or gel formulation is a promising alternative intracanal medicament.

1 March 2016 in Journal of Invertebrate Pathology
Verified
Journal Article
Closed access
SHSELCUK HAZIR
SELCUK HAZIR
David Shapiro IlanDavid Shapiro Ilan
David Shapiro Ilan
CHCanan Hazir
Canan Hazir
LLLuis G. Leite
Luis G. Leite
ICIbrahim Cakmak
Ibrahim Cakmak
DODawn Olson
Dawn Olson

1 January 2025 in Journal of Pest Science
Verified
Journal Article
Closed access
PDF file
RRRamalingam Karthik Raja
Ramalingam Karthik Raja
Prabu kumar SeetharamanPrabu kumar Seetharaman
Prabu kumar Seetharaman
GBGovindasamy Balasubramani
Govindasamy Balasubramani
CSChellappa Sankaranarayanan
Chellappa Sankaranarayanan
BLBo Liu
Bo Liu
MNMathiyazhagan Narayanan
Mathiyazhagan Narayanan